Search
for
Did you mean Glucocorticoid Resistance?
Sort by
Research 30 of 1000+
- Glucocorticoid Resistance Syndrome in 2 Patients With Diverse Genotype
- The Glucocorticoid Resistance Syndrome. Two Cases of a Novel Pathogenic Variant in the Glucocorticoid Receptor Gene
- LBODP010 A Case of Glucocorticoid Resistance Syndrome
- Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor
- Novel insights into the molecular mechanisms underlying generalized glucocorticoid resistance and hypersensitivity syndromes
- 5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis
- Disrupted Pancreatic Exocrine Differentiation and Malabsorption in Response to Chronic Elevated Systemic Glucocorticoid
- The Polycystic Ovary Syndrome and Acne
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Acne-Associated Syndromes
- 5α-Reductase Type 1 Deficiency or Inhibition Predisposes to Insulin Resistance, Hepatic Steatosis, and Liver Fibrosis in Rodents
- Rare Challenges in Diagnosing Cushing’s Syndrome and Primary Aldosteronism: A Case Report of a Female With a Negative Workup
- [Hirsutism and hypertrichosis in adults: investigations and treatment].
- Mucocutaneous Manifestations of Endocrine Disorders
- Treatment options for polycystic ovary syndrome
- Skin and metabolic syndrome: A review of the possible associations
- Hormone therapy in acne
- Female Pseudohermaphroditism Caused by a Novel Homozygous Missense Mutation of the GR Gene
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- The investigation of insulin resistance and metabolic syndrome in male patients with early-onset androgenetic alopecia
- A variant of the glucocorticoid receptor gene is not associated with adrenal androgen excess in women with polycystic ovary syndrome
- Generalised Glucocorticoid Resistance
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome
- Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity
- Treatment of hyperandrogenism in polycystic ovary syndrome
- 5α-Reduced glucocorticoids: a story of natural selection
- Targets to treat androgen excess in polycystic ovary syndrome
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Polycystic Ovary Syndrome in Adolescents